Latest data from large TAVI registries

Session comprising selected EuroPCR 2015 abstract submissions

Chairperson: L. Büllesfeld
Panellists: A. Finkelstein, J. Hon

Presentations available when logged in:

  • 3-year midterm post-approval study outcomes with a second-generation balloon-expandable transcatheter heart valve
  • The impact of device evolution on the incidence of procedural complications: a report on the Edwards third-generation valve system in 2,154 patients
  • 3-year midterm haemodynamic and durability outcomes of the European pivotal trial for second-generation balloon-expandable transcatheter heart valves
  • 3-year clinical and echocardiographic follow-up of aortic stenosis patients implanted with a self-expanding bioprosthesis
  • 5-year outcome after TAVI with CoreValve prosthesis